Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Growth stocks coverage continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Growth stocks coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Growth stocks coverage continues on .com
Go to Proactive UK

Finance

Chesnara PLC CSN View profile

Chesnara shares climb as brokers back acquisition-driven cash growth

Shares in Chesnara PLC (LSE:CSN), the FTSE Small Cap life insurance consolidator, rose 4% to 343p after first-half results showed its largest acquisition beginning to feed into capital generation.

Two brokers reaffirmed buy recommendations following the numbers.

Panmure Liberum, which acts as corporate broker to the company, holds a target price of 400p, implying further upside of more than 16% from the new level.

Peel Hunt is markedly more cautious, with a buy rating but a target price of 330p, now below where the shares are trading.

The gap between the two reflects differing views on how much of the acquisition benefit is durable.

Operating capital generation, a measure of the cash the business throws off, reached £96 million in the first half, up 78% from £54 million a year earlier.

Panmure Liberum analyst Abid Hussain noted that roughly £50 million of that was a one-off benefit from owning HSBC UK Life, now rebranded Chesnara Life UK.

About £10 million came from diversification benefits, which reduce the capital the enlarged group must hold, with the remaining £40 million from extending a mass lapse reinsurance arrangement and optimising a deferred tax programme.

That leaves around £45 million of recurring generation, covering the interim dividend 2.4 times on the recurring elements alone.

Adjusted operating profit before tax rose 48% to £31 million, from £21 million, helped by five months of contribution from the UK acquisition and solid performance in the Netherlands, partially offset by adverse persistency in Sweden.

Peel Hunt pointed out that the headline result included £23 million of restructuring costs tied to the various transactions, with negligible investment variances.

Statutory profit after tax was just £0.6 million, against a loss of £11 million a year earlier, distorted by a tax charge attributable to policyholders.

The Solvency II coverage ratio, a regulatory measure of capital strength, fell to 185% from 257% at the year end as the HSBC book was onboarded.

Both brokers expect it to remain above the group's 140% to 160% target range once the acquisition of Scottish Widows Europe completes at the end of the year.

Cash remittances from the divisions rose to £73 million from £56 million, according to Peel Hunt, funding an interim dividend of 8.16p, up 6%.

That marks the 22nd consecutive year of dividend growth since the company floated in 2004.

Panmure argues the two acquisitions create a positive inflexion in free cash flow, with the HSBC deal adding roughly £28 million of cash a year over five years and Scottish Widows Europe a further £17 million from 2027.

The broker forecasts dividend cover from cash of 2.0 times by 2028 and estimates management retains more than £130 million of firepower for further deals before fresh capital would be needed.

Peel's target, now surpassed by the share price, suggests it sees the deal benefits as largely already in the price.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Growth stocks coverage continues on .com
Go to Proactive UK

Today’s Edition